Hanazaki K, Wakabayashi M, Sodeyama H, Miyazawa M, Yokoyama S, Sode Y, Kawamura N, Miyazaki T, Ohtsuka M
Department of Surgery, Nagano Red Cross Hospital, Nagano, Japan.
J Clin Gastroenterol. 1997 Apr;24(3):150-5. doi: 10.1097/00004836-199704000-00006.
A retrospective study of 155 patients with submucosal gastric carcinoma compared the clinicopathologic features with mucosal and muscularis proprial gastric carcinoma. Fifty-seven percent of the patients presented with gastrointestinal symptoms, whereas 36.1% had been detected by mass screening. The incidence of curative resection, lymph node metastasis, and complications were 96.1, 20.6, and 14.8%, respectively. Two patients died of sepsis and pulmonary infarction 30 days post-operatively. Five patients died of recurrent gastric cancer 1-5 years postresection. The overall 5-year survival rate was 90.2%. Recurrence patterns, histologic type, lymph node metastasis, lymphatic and venous infiltration, and growth pattern were similar to those of muscularis proprial carcinoma rather than mucosal carcinoma. Therefore, curative gastrectomy with extended lymphadenectomy (D2) may be feasible for submucosal carcinoma of the stomach.
一项针对155例胃黏膜下癌患者的回顾性研究,比较了其与胃黏膜癌和胃肌层癌的临床病理特征。57%的患者出现胃肠道症状,而36.1%是通过大规模筛查发现的。根治性切除、淋巴结转移和并发症的发生率分别为96.1%、20.6%和14.8%。两名患者术后30天死于败血症和肺梗死。五名患者在切除术后1至5年死于复发性胃癌。总体5年生存率为90.2%。复发模式、组织学类型、淋巴结转移、淋巴管和静脉浸润以及生长模式与胃肌层癌相似,而非胃黏膜癌。因此,对于胃黏膜下癌,行根治性胃切除术加扩大淋巴结清扫术(D2)可能是可行的。